eRF1 Antibodies

Santa Cruz Biotechnology provides a broad selection of eRF1 monoclonal antibodies for advanced research in molecular biology. eRF1 monoclonal antibodies are compatible with multiple applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). eRF1, or eukaryotic release factor 1, plays a crucial role in the termination of protein synthesis by recognizing stop codons during translation. eRF1 maintains the fidelity of protein synthesis and participates in various cellular processes, making it a significant target for research in gene expression and regulation. Understanding eRF1 function can provide insights into the mechanisms of translation and its implications in diseases related to protein synthesis dysregulation. Researchers can utilize eRF1 monoclonal antibodies to investigate protein synthesis mechanisms and their impact on cellular function. eRF1 monoclonal antibodies enable detailed examination of translation termination processes and their regulation in different biological systems. Santa Cruz Biotechnology monoclonal antibodies support researchers worldwide in advancing our understanding of fundamental cellular processes and potential therapeutic applications.